These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 6431172

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rifampicin in the retreatment and original treatment of advanced pulmonary tuberculosis.
    Gyselen A.
    Bull Int Union Tuberc; 1970 Jun; 43():60-3. PubMed ID: 4987555
    [No Abstract] [Full Text] [Related]

  • 3. [Rifampicin in the treatment of patients with chronic destructive tuberculosis complicated by drug intolerance and Mycobacterium drug resistance].
    Adamovich VN, Kolomytseva OS, Gur'ian IE.
    Vrach Delo; 1975 Jan; (1):95-9. PubMed ID: 806177
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical studies on the bacterial resistance to rifampicin].
    Sakurai H, Inoue I, Yamagami K.
    Kekkaku; 1972 Dec; 47(12):475-9. PubMed ID: 4631478
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Study of rifampicin in the treatment of tuberculosis and nonspecific inflammatory lung diseases].
    Rudoĭ NM, Zankisova IG, Eĭsaev BA.
    Antibiotiki; 1975 Oct; 20(10):945-8. PubMed ID: 813565
    [Abstract] [Full Text] [Related]

  • 7. [Changes in the incidence of microscopically positive findings along with negative culture of M. tuberculosis in patients treated with rifampicin].
    Popovic I, Begovic N.
    Plucne Bolesti Tuberk; 1975 Oct; 27(1-2):47-52. PubMed ID: 808808
    [No Abstract] [Full Text] [Related]

  • 8. [Bacteriologic negation and anatomic development in pulmonary specimens after rifampicin treatment of less than 10 months (10 cases)].
    Constans P, Parrot R, Coury C.
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):511-8. PubMed ID: 4994883
    [No Abstract] [Full Text] [Related]

  • 9. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B, Pretet S.
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(3):429-33. PubMed ID: 4994940
    [No Abstract] [Full Text] [Related]

  • 10. [Dynamics of rifampicin and ethambutol resistance of strains of Koch bacilli isolated from patients with pulmonary tuberculosis 1973-1981].
    Ionescu C, Timoşca S, Petreanu V, Petreanu C, Georgescu M, Martinescu T.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982 Jun; 31(4):315-20. PubMed ID: 6304845
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Therapeutic effects of treatment with RFP on previously treated cases of pulmonary tuberculosis (author's transl)].
    Sakurai H, Watanabe Y, Yamanaka M, Moriguchi T, Fujii K, Uenoyama T.
    Kekkaku; 1980 Nov; 55(11):485-91. PubMed ID: 6780716
    [No Abstract] [Full Text] [Related]

  • 13. [Rifampicin and ethanbutol in daily and intermittent treatment of chronic advanced cavernous pulmonary tuberculosis resistant to many drugs. Preliminary communication. Early results].
    Zierski M, Bek E, Kucharska A, Graczyk J, Bukalska Z.
    Gruzlica; 1973 Nov; 41(11):1129-37. PubMed ID: 4765793
    [No Abstract] [Full Text] [Related]

  • 14. [Therapeutic failure in the application of rifampin (RFP): evaluation and management].
    Yamazaki M.
    Kekkaku; 1983 Sep; 58(9):498-501. PubMed ID: 6420604
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Monotherapy of chronic pulmonary tuberculosis using Rimactan. Report on a 3-month-long therapeutic series].
    Hofmann F.
    Schweiz Med Wochenschr; 1968 Sep 07; 98(36):1363-7. PubMed ID: 4971389
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Three-year follow-up results of the first clinical study on the daily and twice-weekly administrations of rifampicin, investigated by the Tuberculosis Research Committee, Ryoken (author's transl)].
    Kekkaku; 1974 Apr 07; 49(4):107-12. PubMed ID: 4411274
    [No Abstract] [Full Text] [Related]

  • 20. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH, Patientia RF, Venter A, van Helden PD, Smith PJ, McIlleron H, Maritz JS, Donald PR.
    Antimicrob Agents Chemother; 2007 Aug 07; 51(8):2994-6. PubMed ID: 17517849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.